US Patent 7709641 NK1 antagonists
Patent 7709641 was granted and assigned to Opko Health, Inc. on May, 2010 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7709641 NK1 antagonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
